{"id":"https://openalex.org/W2070136629","doi":"https://doi.org/10.1185/03007995.2015.1036016","title":"Efficacy and safety of fluticasone furoate/vilanterol (50/25 mcg; 100/25 mcg; 200/25 mcg) in Asian patients with chronic obstructive pulmonary disease: a randomized placebo-controlled trial","display_name":"Efficacy and safety of fluticasone furoate/vilanterol (50/25 mcg; 100/25 mcg; 200/25 mcg) in Asian patients with chronic obstructive pulmonary disease: a randomized placebo-controlled trial","publication_year":2015,"publication_date":"2015-04-01","ids":{"openalex":"https://openalex.org/W2070136629","doi":"https://doi.org/10.1185/03007995.2015.1036016","mag":"2070136629","pmid":"https://pubmed.ncbi.nlm.nih.gov/25830381"},"language":"en","primary_location":{"id":"doi:10.1185/03007995.2015.1036016","doi":"https://doi.org/10.1185/03007995.2015.1036016","is_oa":false,"landing_page_url":"https://doi.org/10.1185/03007995.2015.1036016","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://figshare.com/articles/journal_contribution/Efficacy_and_safety_of_fluticasone_furoate_vilanterol_50_25_mcg_100_25_mcg_200_25_mcg_in_Asian_patients_with_chronic_obstructive_pulmonary_disease_a_randomized_placebo-controlled_trial/4970231","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036141800","display_name":"Jinping Zheng","orcid":"https://orcid.org/0000-0002-7511-661X","observed_orcids":["https://orcid.org/0000-0002-7511-661X"]},"institutions":[{"id":"https://openalex.org/I4210098361","display_name":"First Affiliated Hospital of Guangzhou Medical University","ror":"https://ror.org/00z0j0d77","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210098361"]},{"id":"https://openalex.org/I4210154954","display_name":"State Key Laboratory of Respiratory Disease","ror":"https://ror.org/04hja5e04","country_code":"CN","type":"facility","lineage":["https://openalex.org/I4210154954"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jinping Zheng","raw_affiliation_strings":["aState Key Lab of Respiratory Disease, National Clinical Research Centre of Respiratory Disease, 1st Affiliated Hospital of Guangzhou Medical University, Guangzhou, China","State Key Lab of Respiratory Disease, National Clinical Research Centre of Respiratory Disease, 1st Affiliated Hospital of Guangzhou Medical University , Guangzhou , China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aState Key Lab of Respiratory Disease, National Clinical Research Centre of Respiratory Disease, 1st Affiliated Hospital of Guangzhou Medical University, Guangzhou, China","institution_ids":["https://openalex.org/I4210098361"]},{"raw_affiliation_string":"State Key Lab of Respiratory Disease, National Clinical Research Centre of Respiratory Disease, 1st Affiliated Hospital of Guangzhou Medical University , Guangzhou , China","institution_ids":["https://openalex.org/I4210098361","https://openalex.org/I4210154954"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049148263","display_name":"Teresita De Guia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155360","display_name":"Philippine Heart Center","ror":"https://ror.org/050rdvn58","country_code":"PH","type":"healthcare","lineage":["https://openalex.org/I4210155360"]}],"countries":["PH"],"is_corresponding":false,"raw_author_name":"Teresita de Guia","raw_affiliation_strings":["bPhilippine Heart Center, Quezon City, Philippines"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"bPhilippine Heart Center, Quezon City, Philippines","institution_ids":["https://openalex.org/I4210155360"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007196646","display_name":"Jie Wang\u2010Jairaj","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jie Wang-Jairaj","raw_affiliation_strings":["cRespiratory Medicines Development Centre, GSK, Uxbridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"cRespiratory Medicines Development Centre, GSK, Uxbridge, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044702185","display_name":"Amy Newlands","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Amy H. Newlands","raw_affiliation_strings":["dQuantitative Sciences Division, GSK, Uxbridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"dQuantitative Sciences Division, GSK, Uxbridge, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100661089","display_name":"Changzheng Wang","orcid":"https://orcid.org/0000-0002-8991-1315","observed_orcids":["https://orcid.org/0000-0002-8991-1315"]},"institutions":[{"id":"https://openalex.org/I4210117763","display_name":"Xinqiao Hospital","ror":"https://ror.org/02d217z27","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210117763"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Changzheng Wang","raw_affiliation_strings":["eRespiratory Department, Xinqiao Hospital, Chongqing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"eRespiratory Department, Xinqiao Hospital, Chongqing, China","institution_ids":["https://openalex.org/I4210117763"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079023447","display_name":"Courtney C. Crim","orcid":"https://orcid.org/0000-0002-3391-2490","observed_orcids":["https://orcid.org/0000-0002-3391-2490"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Courtney Crim","raw_affiliation_strings":["fRespiratory Medicines Development Centre, GSK, Research Triangle Park, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"fRespiratory Medicines Development Centre, GSK, Research Triangle Park, NC, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101475024","display_name":"Nanshan Zhong","orcid":"https://orcid.org/0000-0003-2274-1427","observed_orcids":["https://orcid.org/0000-0003-2274-1427","https://orcid.org/0009-0005-1707-9119"]},"institutions":[{"id":"https://openalex.org/I4210098361","display_name":"First Affiliated Hospital of Guangzhou Medical University","ror":"https://ror.org/00z0j0d77","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210098361"]},{"id":"https://openalex.org/I4210154954","display_name":"State Key Laboratory of Respiratory Disease","ror":"https://ror.org/04hja5e04","country_code":"CN","type":"facility","lineage":["https://openalex.org/I4210154954"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Nanshan Zhong","raw_affiliation_strings":["aState Key Lab of Respiratory Disease, National Clinical Research Centre of Respiratory Disease, 1st Affiliated Hospital of Guangzhou Medical University, Guangzhou, China","State Key Lab of Respiratory Disease, National Clinical Research Centre of Respiratory Disease, 1st Affiliated Hospital of Guangzhou Medical University , Guangzhou , China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aState Key Lab of Respiratory Disease, National Clinical Research Centre of Respiratory Disease, 1st Affiliated Hospital of Guangzhou Medical University, Guangzhou, China","institution_ids":["https://openalex.org/I4210098361"]},{"raw_affiliation_string":"State Key Lab of Respiratory Disease, National Clinical Research Centre of Respiratory Disease, 1st Affiliated Hospital of Guangzhou Medical University , Guangzhou , China","institution_ids":["https://openalex.org/I4210098361","https://openalex.org/I4210154954"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5101475024"],"corresponding_institution_ids":["https://openalex.org/I4210098361","https://openalex.org/I4210154954"],"apc_list":null,"apc_paid":null,"fwci":1.6285,"has_fulltext":false,"cited_by_count":37,"citation_normalized_percentile":{"value":0.84267711,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"31","issue":"6","first_page":"1191","last_page":"1200"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.006099999882280827,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fluticasone-furoate-vilanterol","display_name":"fluticasone furoate/vilanterol","score":0.9950000047683716},{"id":"https://openalex.org/keywords/chronic-obstructive-pulmonary-disease","display_name":"chronic obstructive pulmonary disease","score":0.9869999885559082},{"id":"https://openalex.org/keywords/asian-patients","display_name":"Asian patients","score":0.9739999771118164},{"id":"https://openalex.org/keywords/inhaled-corticosteroid-long-acting-beta2-agonist-combination","display_name":"inhaled corticosteroid/long-acting beta2-agonist combination","score":0.8009999990463257},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.5690000057220459},{"id":"https://openalex.org/keywords/trough-fev1","display_name":"trough FEV1","score":0.8420000076293945},{"id":"https://openalex.org/keywords/lung-function","display_name":"lung function","score":0.9409999847412109},{"id":"https://openalex.org/keywords/albuterol-use","display_name":"albuterol use","score":0.656000018119812},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8930000066757202},{"id":"https://openalex.org/keywords/dry-powder-inhaler","display_name":"dry powder inhaler","score":0.7260000109672546},{"id":"https://openalex.org/keywords/bronchodilator-therapy","display_name":"bronchodilator therapy","score":0.6520000100135803},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.5799999833106995},{"id":"https://openalex.org/keywords/pneumonia","display_name":"pneumonia","score":0.5920000076293945},{"id":"https://openalex.org/keywords/urinary-cortisol","display_name":"urinary cortisol","score":0.7459999918937683},{"id":"https://openalex.org/keywords/electrocardiography","display_name":"electrocardiogram","score":0.8289999961853027}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9635148048400879},{"id":"https://openalex.org/C2779028295","wikidata":"https://www.wikidata.org/wiki/Q8564098","display_name":"Fluticasone propionate","level":3,"score":0.710922122001648},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5916755199432373},{"id":"https://openalex.org/C2992779976","wikidata":"https://www.wikidata.org/wiki/Q3286546","display_name":"Pulmonary disease","level":2,"score":0.5745015144348145},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5312578082084656},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4472549259662628},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.34633058309555054},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.17132776975631714},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.09661313891410828},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000280","descriptor_name":"Administration, Inhalation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000420","descriptor_name":"Albuterol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000730","descriptor_name":"Androstadienes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000730","descriptor_name":"Androstadienes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001592","descriptor_name":"Benzyl Alcohols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001592","descriptor_name":"Benzyl Alcohols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002722","descriptor_name":"Chlorobenzenes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D002722","descriptor_name":"Chlorobenzenes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005938","descriptor_name":"Glucocorticoids","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006854","descriptor_name":"Hydrocortisone","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D029424","descriptor_name":"Pulmonary Disease, Chronic Obstructive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D044466","descriptor_name":"Asian People","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058995","descriptor_name":"Dry Powder Inhalers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1185/03007995.2015.1036016","doi":"https://doi.org/10.1185/03007995.2015.1036016","is_oa":false,"landing_page_url":"https://doi.org/10.1185/03007995.2015.1036016","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},{"id":"pmid:25830381","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25830381","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medical research and opinion","raw_type":"Comparative Study"},{"id":"pmh:oai:figshare.com:article/4970231","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Efficacy_and_safety_of_fluticasone_furoate_vilanterol_50_25_mcg_100_25_mcg_200_25_mcg_in_Asian_patients_with_chronic_obstructive_pulmonary_disease_a_randomized_placebo-controlled_trial/4970231","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"},{"id":"doi:10.6084/m9.figshare.4970231.v1","doi":"https://doi.org/10.6084/m9.figshare.4970231.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.4970231.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"}],"best_oa_location":{"id":"pmh:oai:figshare.com:article/4970231","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Efficacy_and_safety_of_fluticasone_furoate_vilanterol_50_25_mcg_100_25_mcg_200_25_mcg_in_Asian_patients_with_chronic_obstructive_pulmonary_disease_a_randomized_placebo-controlled_trial/4970231","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1740581730","https://openalex.org/W1978950822","https://openalex.org/W1987328106","https://openalex.org/W2017600141","https://openalex.org/W2018370315","https://openalex.org/W2027913623","https://openalex.org/W2040063897","https://openalex.org/W2049267258","https://openalex.org/W2108060426","https://openalex.org/W2110432885","https://openalex.org/W2127104182","https://openalex.org/W2127951128","https://openalex.org/W2129633626","https://openalex.org/W2130795051","https://openalex.org/W2132170452","https://openalex.org/W2132439698","https://openalex.org/W2134904172","https://openalex.org/W2136236608","https://openalex.org/W2156523739"],"related_works":["https://openalex.org/W2116744855","https://openalex.org/W2105984267","https://openalex.org/W2129633626","https://openalex.org/W1899858731","https://openalex.org/W2469200969","https://openalex.org/W6929854477","https://openalex.org/W2130795051","https://openalex.org/W3032870752","https://openalex.org/W2558984684","https://openalex.org/W4386305629"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1],"OBJECTIVE:":[2],"Three":[3],"strengths":[4,50,135,154,233],"of":[5,15,24,35,46,51,136,146,155,161,179,234,266],"fluticasone":[6],"furoate/vilanterol":[7],"(FF/VI)":[8],"were":[9,80,131,218],"previously":[10],"evaluated":[11,41],"for":[12,220,263],"the":[13,42,47,96,193,264],"treatment":[14,200,214,265],"chronic":[16],"obstructive":[17],"pulmonary":[18],"disease":[19],"(COPD)":[20],"in":[21,54,109,128,256],"a":[22,32,197],"program":[23],"global":[25],"Phase":[26],"3":[27],"studies":[28],"that":[29,250],"included":[30],"only":[31,195],"small":[33],"subgroup":[34],"Asian":[36,55,257],"patients.":[37,56,121],"This":[38],"study":[39,194],"further":[40],"efficacy":[43,103],"and":[44,73,172,202,229],"safety":[45,242],"same":[48],"three":[49],"FF/VI":[52,85,137,156,169,186,235,260],"exclusively":[53],"METHODS:":[57],"A":[58],"randomized,":[59],"double-blind,":[60],"placebo-controlled,":[61],"parallel-group,":[62],"multicenter":[63],"study.":[64],"Patients":[65],"with":[66,133,152,168,174,185,190,239],"post-bronchodilator":[67],"FEV1/FVC":[68],"\u22640.70,":[69],"FEV1":[70,111,130],"\u226470%":[71],"predicted":[72],"modified":[74],"Medical":[75],"Research":[76],"Council":[77],"score":[78],"\u22652":[79],"randomized":[81],"(1:1:1:1)":[82],"to":[83,206,248],"placebo,":[84],"50/25":[86],"mcg,":[87],"100/25":[88,261],"mcg":[89,92,171,262],"or":[90],"200/25":[91,170],"once":[93],"daily":[94],"via":[95],"ELLIPTA":[97],"dry":[98],"powder":[99],"inhaler.":[100],"The":[101,116,159,177],"primary":[102],"endpoint":[104],"was":[105,150,166,183,203],"change":[106],"from":[107],"baseline":[108],"trough":[110,129],"at":[112,140],"Week":[113,141],"24.":[114],"RESULTS:":[115],"intent-to-treat":[117],"population":[118],"comprised":[119],"643":[120],"Statistically":[122],"significant":[123,213],"(p":[124],"<":[125],"0.001)":[126],"improvements":[127],"observed":[132,151],"all":[134,153],"versus":[138,157,188,216],"placebo":[139,217],"24":[142,224],"(0.14-0.19":[143],"L).":[144],"Reduction":[145],"supplemental":[147],"albuterol":[148],"use":[149],"placebo.":[158],"incidence":[160,178],"on-treatment":[162,180],"adverse":[163],"events":[164],"(AEs)":[165],"48%":[167],"37-40%":[173],"other":[175],"treatments.":[176],"serious":[181],"AEs":[182],"4-9%":[184],"treatments":[187],"9%":[189],"placebo;":[191],"however,":[192],"covered":[196],"6":[198],"month":[199],"period":[201],"not":[204],"powered":[205],"assess":[207],"effects":[208,215],"on":[209],"exacerbations.":[210],"No":[211],"clinically":[212],"identified":[219],"electrocardiogram,":[221],"vital":[222],"signs,":[223],"hour":[225],"urinary":[226],"cortisol":[227],"excretion":[228],"pneumonia.":[230],"CONCLUSIONS:":[231],"All":[232],"improved":[236],"lung":[237],"function":[238],"an":[240],"acceptable":[241],"profile.":[243],"There":[244],"is":[245],"no":[246],"evidence":[247],"suggest":[249],"dose":[251],"adjustment":[252],"may":[253],"be":[254],"required":[255],"patients":[258],"using":[259],"COPD.":[267],"CLINICAL":[268],"TRIAL":[269],"REGISTRATION:":[270],"NCT01376245.":[271]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":16},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}